Wei Jingjing, Li Mingming, Du Lingyun, Lv Shanrong, Leng Yi, Zhao Xiaoke, Yu Kemei, Xu Qingqing, Zhang Chunhong
Department of Dermato-Venereology, the Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Department of Dermato-Venereology, the Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Bioorg Chem. 2025 Aug;163:108711. doi: 10.1016/j.bioorg.2025.108711. Epub 2025 Jun 27.
Psoriasis is a common chronic immune-inflammatory skin disease that remains a challenge to treat. Benzoylpaeoniflorin (BPF) is a monoterpenoid glycoside derived from the roots of Paeonia albiflora Pall., a plant in the peony family (Paeoniaceae). It has shown promising anti-inflammatory effects. However, its therapeutic efficacy in psoriasis has not yet been investigated. This study aims to evaluate the therapeutic effects of BPF in Imiquimod (IMQ)-induced psoriasis-like lesions and to elucidate its underlying mechanisms.
The psoriasis-like model was established in SKH-1 mice using IMQ to evaluate the in vivo efficacy of BPF. Flow cytometry was employed to analyze the proportions of immune cells in the spleen and peripheral blood of the mice. RNA-sequencing was used to screen the differentially expressed genes and key signaling pathways in BPF-treated mice. Molecular docking was used to simulate the binding mode of BPF and potential targets. The human keratinocytes cells (HaCaT) and bone marrow-derived dendritic cells (BMDCs) were used to assess the inhibitory effects of BPF on cell proliferation, cell maturation and the activation of the TNF-α/NF-κB signaling pathway.
BPF improved the clinical symptoms and histological features of psoriasis-like lesions in IMQ-treated SKH-1 mice. BPF reduced the proportions of lymphocytes and dendritic cells (DCs), modulated the ratio of Th17/Treg cells and promoted immune balance restoration. RNA-sequencing analysis showed that BPF ameliorated psoriasis by modulating multiple immune-related and cytokine-associated signaling pathways, including the NF-κB, TNF-α, and IL-17 signaling pathways. Molecular docking demonstrated that BPF may play an anti-psoriasis role by interfering with the formation of TNF-α trimer and binding TNF-α to TNF-R. BPF inhibited TNF-α-induced proliferation of HaCaT cells and maturation of DCs, as well as TNF-α-induced activation of NF-κB and secretion of inflammatory cytokines.
BPF alleviates psoriasis-like inflammation through multiple mechanisms, offering new insights into potential therapeutic strategies.
银屑病是一种常见的慢性免疫炎症性皮肤病,治疗仍具挑战性。苯甲酰芍药苷(BPF)是一种从芍药科植物白芍根中提取的单萜糖苷。它已显示出有前景的抗炎作用。然而,其在银屑病中的治疗效果尚未得到研究。本研究旨在评估BPF对咪喹莫特(IMQ)诱导的银屑病样病变的治疗效果,并阐明其潜在机制。
使用IMQ在SKH-1小鼠中建立银屑病样模型,以评估BPF的体内疗效。采用流式细胞术分析小鼠脾脏和外周血中免疫细胞的比例。RNA测序用于筛选BPF处理小鼠中差异表达的基因和关键信号通路。分子对接用于模拟BPF与潜在靶点的结合模式。使用人角质形成细胞(HaCaT)和骨髓来源的树突状细胞(BMDCs)评估BPF对细胞增殖、细胞成熟以及TNF-α/NF-κB信号通路激活的抑制作用。
BPF改善了IMQ处理的SKH-1小鼠银屑病样病变的临床症状和组织学特征。BPF降低了淋巴细胞和树突状细胞(DCs)的比例,调节了Th17/Treg细胞的比例,并促进免疫平衡恢复。RNA测序分析表明,BPF通过调节多种免疫相关和细胞因子相关信号通路改善银屑病,包括NF-κB、TNF-α和IL-17信号通路。分子对接表明,BPF可能通过干扰TNF-α三聚体的形成并将TNF-α与TNF-R结合而发挥抗银屑病作用。BPF抑制TNF-α诱导的HaCaT细胞增殖和DCs成熟,以及TNF-α诱导的NF-κB激活和炎性细胞因子分泌。
BPF通过多种机制减轻银屑病样炎症,为潜在治疗策略提供了新见解。